Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06103136 · ClinicalTrials.gov registry record
Maestro 1.1 Post-Market Registry
A clinical trial of Surgery, sponsored by Moon Surgical.
- Recruiting
- Registry status
- 600
- Enrollment target
- 12
- Study locations
NCT06103136: Recruiting study of Surgery, sponsored by Moon Surgical.
NCT06103136 is a study of Surgery that is actively recruiting participants, run by Moon Surgical. The registered enrollment target is 600 participants, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 12 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06103136, a study of Surgery, is actively recruiting participants, sponsored by Moon Surgical.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 12
- Study locations
Study Summary
The objective of the study is to observe the real-life usage of the Maestro Platform for surgical assistance in laparoscopic surgery.
Conditions Studied
Interventions
- DEVICE Laparoscopic surgery using the Maestro Platform
Study Locations (12)
Other
- Chirec Delta - Auderghem
- Polyclinique de Franche-Comté - Besançon
- Clinique Bouchard - Marseille
- Institut Arnault Tzanck - Saint-Laurent-du-Var
- Clinique de l'Orangerie - Strasbourg
Florida
- Lee Health - Fort Myers
- Baptist Health - Jacksonville
- Baptist Medical Center Beaches - Jacksonville
- Orlando Veterans Affairs Medical Center - Orlando
Colorado
- Rose Medical Center - Denver
Texas
- Surgeon's Point ASC - Cedar Park
Alpes Maritimes
- Hôpital Privé Arnault Tzanck - Mougin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2023-09-29 |
| Est. Completion | 2025-12 |
What NCT06103136 shows while recruiting
NCT06103136 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Laparoscopic surgery using the Maestro Platform is the first listed.
NCT06103136 lists 12 locations in 5 states (Other, Florida, Colorado).
Frequently Asked Questions
What is clinical trial NCT06103136 about?
NCT06103136 is a clinical study titled "Maestro 1.1 Post-Market Registry". The objective of the study is to observe the real-life usage of the Maestro Platform for surgical assistance in laparoscopic surgery.
What is the current status of trial NCT06103136?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2023-09-29. Estimated completion is 2025-12.
What conditions does trial NCT06103136 study?
This clinical trial studies the following conditions: Surgery.
What interventions are being tested in trial NCT06103136?
The interventions under investigation include: Laparoscopic surgery using the Maestro Platform (DEVICE).
Who is sponsoring clinical trial NCT06103136?
This trial is sponsored by Moon Surgical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06103136 being conducted?
This trial has 12 study locations across Colorado, Florida, Texas, Alpes Maritimes. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06103136's enrollment target sits among peer trials
600 21st of 120 higher than 100 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Terumo Aortic Global Endovascular Registry
RECRUITING
-
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
RECRUITING · NA
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
RECRUITING · NA
-
Ultrasound Evaluation for Improving Patient Selection in vNOTES
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI